// App-Quantinova.ai

234P : CIRCULATING TUMOR CELLS AS BIOMARKERS DURING NEOADJUVANT CHEMOTHERAPY IN BLADDER CANCER

Researchers

Presenter

  • A.S. Alva

Principal Investigators

  • M. Clark

  • S. Daignault-Newton

  • T. Huebner

  • R. Mehra

  • C. Ionescu

  • M. Schwartz

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Fluxion Biosciences,

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • Circulating tumor cells

  • Epidermal growth factor receptor

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved